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Cellular signalling: Stressing the importance of PIP3
Katherine A. Hinchliffe
The lipid second messenger PIP3 was previously
thought to be generated exclusively by type I
PI 3-kinases. Now, a novel route of PIP3 synthesis,
controlled by an unrelated enzyme family, has been
discovered, increasing our understanding of the
versatility of PIP3 in cellular signalling.
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Since its discovery in the late 1980s [1,2], the phospholipid
phosphatidylinositol(3,4,5)P3 (PIP3) has become estab-
lished as an important mediator of signal transduction in
numerous eukaryotic systems [3,4]. Although virtually
undetectable in unstimulated cells, PIP3 levels increase
markedly in response to a variety of stimuli. Specific
binding proteins are then recruited to the membrane
and/or activated by their interaction with the lipid, con-
tributing to the response to stimulation. Many different
PIP3-regulated proteins have been identified, including
protein kinases, guanine nucleotide exchange factors and
phospholipases. The ability of PIP3 to interact with so
many distinct targets suggests that its role in signalling is
complex, different effectors being employed in distinct
contexts to achieve appropriate responses.
The PIP3 generated in response to growth factors is
produced by the phosphorylation of another phospho-
lipid, PI(4,5)P2, at position 3 of its inositol headgroup [5].
After the discovery of this pathway, numerous studies
identified and characterised enzymes, the PI 3-kinases,
responsible for its regulation (reviewed in [3,4]). Differ-
ent PI 3-kinase isoforms are activated by distinct types of
cell surface receptor, enabling PIP3 to act as a mediator
in a range of distinct signalling pathways. Cloning studies
have shown these enzymes to be members of a wider
family, all of which share the common ability to phospho-
rylate inositol at position 3, but which exhibit distinct
preferences for their lipid substrate. These substrate
preferences have led to the subdivision of the PI 3-
kinase family into three classes, only class I enzymes
being able to phosphorylate PI(4,5)P2 and generate PIP3
directly [3].
The intense interest focussed on the PI 3-kinases over the
past decade has tended to overshadow the fact that these
are not the only enzymes that phosphorylate inositol lipids.
In fact, a distinct family of proteins lacking any discernible
sequence homology with the PI 3-kinases also plays a
major role in this process: the phosphatidylinositol phos-
phate kinases (PIP kinases; reviewed in [6]). These
enzymes were initially identified as regulators of PI(4,5)P2
synthesis, and this is clearly one of their major functions,
but recent studies have shown them to utilise lipid sub-
strates more promiscuously than originally realised [7,8].
This therefore raises the intriguing possibility that the PIP
kinases might generate a wider range of products than ini-
tially suspected. In agreement with this idea, as reported
recently in Current Biology, Halstead and co-workers [9] have
now shown that one PIP kinase subclass, the type I iso-
forms, will generate PIP3 in vivo without the involvement
of type I PI 3-kinases, and that this reaction pathway is
activated when cells are exposed to oxidative stress. In this
case, type I PIP kinases synthesise PIP3 by 5-phosphoryla-
tion of another member of the inositol lipid family,
PI(3,4)P2 (Figure 1).
PI(3,4)P2 was initially identified in one of the studies that
brought PIP3 to prominence [2]. Subsequent analysis of
the kinetics of its appearance within cells suggested that
PI(3,4)P2 is produced by dephosphorylation of PIP3 [5],
and a number of phosphatases able to catalyse this reaction
are now known [10]. However, far from being merely an
uninteresting breakdown product, it is now clear that
PI(3,4)P2 is functionally important in its own right. In par-
ticular, it can activate the protein kinase PKB/Akt, an
important intermediary in numerous signalling pathways
[11]. Unsurprisingly, and in keeping with its role as a sig-
nalling intermediate, PI(3,4)P2 production can be regu-
lated independently of the generation of PIP3 ([12,13] and
see below). It is presumably PI(3,4)P2 synthesised by such
a route that acts as the substrate of the type I PIP kinases
for PIP3 production.
The first indication that the type I PIP kinases have the
potential to generate products other than PI(4,5)P2 came
from the finding that recombinant human type I PIP kinases
can make PIP3 in vitro [7]. This surprising result was sub-
sequently confirmed by work on the murine type Iα and β
PIP kinases, both of which synthesise PIP3 in vitro when
provided with PI(3,4)P2 [8]. However, although in vitro
phosphorylation reactions can be very informative, they do
not always accurately reflect the processes regulated by
particular enzymes physiologically: the type I PI 3-kinases
enthusiastically phosphorylate several inositol lipids in the
test tube, but seem only to utilise PI(4,5)P2 in vivo. The
new findings have addressed this problem, and show that,
in agreement with their activities in vitro, type I PIP
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kinases are, in fact, able to phosphorylate PI(3,4)P2 within
living cells [9].
Halstead et al. [9] found that overexpression of type Iα PIP
kinase, or of the related β and γ isoforms, in Cos-7 cells led to
a marked increase in PIP3 levels, achieved by 5-phosphoryla-
tion of PI(3,4)P2. This increase is not seen if an inactive PIP
kinase mutant is used, demonstrating an absolute require-
ment for the activity of this enzyme. Furthermore, PIP3 syn-
thesis in membranes from the transfected cells is insensitive
to wortmannin, a potent inhibitor of type I PI 3-kinases,
showing that it occurs independently of these proteins.
Wortmannin-insensitive PIP3 synthesis is also stimulated in
membranes from cells exposed to oxidative stress by activa-
tion of an endogenous type I PIP kinase. These data there-
fore demonstrate that the type I PI 3-kinases are not the only
enzymes capable of producing PIP3 physiologically.
It is surprising that the type I PIP kinases contribute to
signalling via PIP3 production, as they also regulate levels
of PI(4,5)P2, itself a multifunctional lipid implicated in
cellular processes as diverse as membrane trafficking and
cytoskeletal regulation [6]. Significantly, levels of PI(4,5)P2,
as well as of PIP3, are elevated in transfected cells produc-
ing exogenous type Iα PIP kinase [9], supporting the idea
that this one enzyme uses multiple substrates in vivo.
Arguably, the ability of a single enzyme to generate
several functionally important products increases its
potential utility to the cell, but this raises the question of
how cells control which reaction is actually carried out. 
Halstead and co-workers [9] found that an endogenous
PI(3,4)P2 5-kinase is constitutively present in membranes
from Cos-7 and MEL cells, but that in the absence of
oxidative stress, PIP3 is not produced unless exogenous
PI(3,4)P2 is supplied. The implication is that the PIP
kinase responsible is not regulated by some unidentified
signal promoting a change in its substrate preferences, but
rather that PIP kinase-mediated PIP3 synthesis may be
regulated by controlling PI(3,4)P2 availability. Interest-
ingly, PI(3,4)P2 production is stimulated by oxidative
stress in Swiss 3T3 cells independently of PI 3-kinase acti-
vation [13], although in this cell line only a very modest
increase in PIP3 levels was detected. It is possible that this
reflects cell-type specific differences in inositol lipid com-
partmentalisation, or type I PIP kinase expression, but this
remains to be established.
As PI(3,4)P2 is also functionally important in its own right,
the question of how its levels are regulated is of great inter-
est. In addition to its production by PIP3 dephosphoryla-
tion, PI(3,4)P2 can also be generated by phosphorylation of
two further inositol lipids, PI(4)P and PI(3)P. The former
reaction can be catalysed by type II PI 3-kinases, members
of the PI 3-kinase superfamily that do not phosphorylate
PI(4,5)P2, and hence do not make PIP3 [3]. In contrast,
although evidence for an enzyme that catalyses 4-phos-
phorylation of PI(3)P has been around for some time [14,
15], its identity remains elusive. One potential candidate is
type II PIP kinase, a near relative of the type I PIP kinases
with distinct substrate preferences [6], which readily
phosphorylates PI3P to PI(3,4)P2 in vitro [7]. However,
immunoprecipitation experiments using type II PIP kinase-
specific antibodies showed a PI(3)P 4-kinase present in
platelets to be a distinct enzyme [15]. Given these alterna-
tive possibilities, the source of the PI(3,4)P2 converted to
Figure 1
Alternative pathways for the synthesis of PIP3.
The second messenger PIP3 is generated
either by the action of type I PI 3-kinase —
activated, for example, by growth factor
stimulation — or, by a newly discovered
mechanism, via type I PIP kinase acting on
PI(3,4)P2. The latter, novel pathway is
activated upon exposure of the cell to
oxidative stress, possibly due to generation of
PI(3,4)P2 via an unidentified mechanism.
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PIP3 by the type I PIP kinases must remain unclear for
now, and future studies on the regulation of this novel
pathway of PIP3 synthesis should address this question. 
What is the purpose of this unexpected complexity in
cells’ ability to regulate PIP3 production? Clearly, cells
have at their disposal a wider repertoire of pathways for
the synthesis of this lipid than previously imagined, increas-
ing yet further the range of circumstances under which it
can be employed as a second messenger. Unfortunately, it
is not yet known which of the many potential effectors of
PIP3 are employed downstream of its generation by PIP
kinases, and how these differ from those utilised when
PIP3 is made by other means. Irrespective of our current
lack of understanding of these factors, however, the fact
remains that the versatility of PIP3 as a signalling molecule
highlights its central role in cellular regulation.
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